fbpx

The Global Effort to End Cancer

Barack Obama

US President Barack Obama has shared his hope that one day America will cure cancer. In his state of the union address on Wednesday, he declared, “For the loved ones we’ve all lost, for the families that we can still save – let’s make America the country that cures cancer once and for all.”

Australian Cancer Research Foundation CEO Professor Ian Brown spoke with ABC Radio National to explain why researchers believe that a cure for cancer really is on the horizon.

“There are statements being made now, that say within a generation, cancer will go from being a source of trepidation, where a sizeable number of people are lost, to one where it will become a treatable disease. And there are very good reasons why we think we’re heading in that direction.

Going back 30-40 years ago, the number of people who were passing away from cancer was quite high and since then researchers have worked to increase our knowledge of the disease substantially.

Today, about 50% of people who contract cancer will survive. But this varies between certain types of cancer. Take thyroid cancer for instance, the survival rates are much higher than they used to be, with more than 95% of people now surviving. However, in a range of other cancers, such as pancreatic cancer or mesothelioma, the survival rates have remained very low.

Over time three main ways have been established as methods to treat most cancers, those are: surgery, radiation therapy and chemotherapy. But over the last 15 years, we have come to understand more about how cancer forms and this has helped shape new treatment methods.

We now know that cancer is basically a mutational change to the genetic information that causes the cells to proliferate abnormally. These cells won’t simply die and our own internal systems aren’t able to kill the tumours. With this understanding, scientists have worked to find new ways to fight this disease.

Medicine is now becoming far more personalised. Information about each individual’s tumour is now being logged into databases. This includes data such as: what the mutation was, what doctors used to try and treat that particular tumour, and whether that treatment was successful, making it far easier for doctors treating the varying mutations that cause different cancers.

The Human Genome Project in 2002 was the first example of such a database, logging all the genetic information that we had. It cost around $3 billion and took twenty years to complete. Whereas, the equipment that we now have, can do this much faster and easier that for less than $1000.

This is why seed funding for upgrading technology and infrastructure is so important. By equipping the best researchers with the right tools, we will speed up discoveries and ultimately save lives.

Science is a collaborative enterprise. People are constantly working to add to our understanding of cancer. We know that by sharing this knowledge around the world, progress is possible. For example, after it was discovered that certain types of viruses could cause cells to become cancerous Australian scientist, Professor Ian Frazer co-developed the cervical cancer vaccine which can now prevent various forms of cancer. This vaccine has now been used in hundreds of millions of people in 120 countries around the world.

So as Obama delcared, America will continue to play an important role in curing cancer, but ending this disease will take global collaboration.”

To listen to the interview: Click here

Millions in private funding set for top cancer scientists in Australia

cancer scientistEvery year the Australian Cancer Research Foundation provides multi-million dollar grants to support research projects of the highest calibre in Australia.

Last week the ACRF Research Advisory Committee met with the six shortlisted applicants to hear more about their proposed projects for research funding. Chaired by Prof. Ian Fraser AC, the Committee is made up of 14 esteemed cancer scientists.

“There has been a particular interest this year in new technology for looking for molecules which fingerprint cancer cells, and for the genetic mistakes that fingerprint cancer cells,” said Prof. Frazer, following the grant interviews.

This year Committee member, A/Prof. Connie Trimble from John Hopkins Hospital in Baltimore, USA, travelled to Australia to join our panel of judges over the two day interview process.  Her experience and perspective on the international research stage will ensure that the successful ACRF grant recipients represent the cutting-edge of world research.

The shortlisted research groups, which were selected based on their significant potential to make an impact on cancer diagnosis, treatment and/or cure, represent a need for almost $25.M in funding.

The six shortlisted applicants are from all over Australia, covering research into all cancers. These are:

  1. Walter & Eliza Hall Institute, Melbourne, VIC
    Develop a purpose-built facility specialising in developing new targeted therapies for all types of cancer.
  2. Monash Institute of Medical Research – Prince Henry Hospital, Melbourne, VIC
    Expansion of an existing ACRF centre to tackle issues such as early detection, tumour diversity and drug resistance.
  3. University of Queensland Centre for Advanced Imaging, Brisbane, QLD
    A facility specialising in the development and validation of novel molecular imaging agents for cancer.
  4. Children’s Cancer Institute, Sydney, NSW
    Create an integrated and dedicated child cancer precision medicine centre, focused on delivering personalised therapies for Australian children at high risk of treatment failure.
  5. Garvan Institute of Medical Research, Sydney, NSW
    Build a space housing super-computer resources for a team of bioinformatics scientists, working towards the analysis of biological changes due to cancer treatment and disease progression.
  6. Sydney University Central Clinical School, Sydney, NSW
    Develop an ACRF imaging centre which will pioneer targeted radiotherapy and provide an opportunity for academia, medicine, industry and government to collaborate on the science and clinical practice of cancer treatment.

The recipients of the 2014 grants will be announced in November. If you would like to read more about our grants process or to find out our past grants recipients please click here.[/vc_column_text][/vc_column][/vc_row]

Skin Cancer Prevention – Promising Results

A study by researchers at Brisbane’s QIMR Berghofer Medical Research Institute has revealed some very promising statistics about one of Australia’s most deadly cancers – Melanoma.

With an estimated 12,000 people diagnosed with melanoma in 2012 it is Australia’s third most common cancer type.

The study, which analysed melanoma cases among 15 to 24 year olds in Queensland from 1982 to 2010, has shown there has been a five per cent a year decline among teenagers and young adults developing the disease from the mid-1990s to 2010.

Additionally, for people aged 20 to 24, the rate has fallen from 25 cases per 100,000 in 1996 to 14 per 100,000 in 2010.

Continue reading “Skin Cancer Prevention – Promising Results”

New leader for top Australian cancer research funding body

The Australian Cancer Research Foundation (ACRF) has appointed distinguished scientist and businessman Dr. Ian Brown as its new Chief Executive.

ACRF’s research grants, which will top the $100 million mark this year, have provided Australia’s best cancer scientists with the technologies, equipment and infrastructure needed to speed up discoveries and stay at the forefront of medical research.

ACRF Chairman Tom Dery said the foundation was thrilled to welcome Dr Brown who is currently an adjunct professor at Flinders University in Adelaide and special visiting professor at the University of Colorado in the US.

Continue reading “New leader for top Australian cancer research funding body”

Study reinforces HPV vaccine is saving lives

Researchers at QIMR Berghofer Medical Research Institute and the University of Queensland have found young women who received the HPV vaccine are far less likely to develop high-risk abnormalities that can lead to cervical cancer.

They used Queensland Health datasets to show these women had a 46 % lower risk of developing high-grade changes in the cervix, compared with women who had not been vaccinated.

Cervical cancer is one of the most common causes of gynaecological cancer, killing more than 200 Australian women every year.

Continue reading “Study reinforces HPV vaccine is saving lives”

$8.4 Million in funding for some of the best cancer research innovations in Australia!

The Australian Cancer Research Foundation has acknowledged the promising future of cancer research in Australia, announcing $8.4million in grants to progress the work of four of the country’s most innovative research initiatives.

In an exciting first, the $8.4m will be shared between research teams from four separate Australian states. The funding will provide each research team with state-of-the-art technologies and facilities, the scope of which have the potential to make significant discoveries in the understanding and management of cancer.

CEO of the ACRF, David Brettell says “Never before have we so many such world-class proposals for cancer research, with applications for our grants this year totalling almost $50 million.”

Continue reading “$8.4 Million in funding for some of the best cancer research innovations in Australia!”

Cancer research foundation funds new treatment centre

The University of Queensland Diamantina Institute has secured a $2 million grant from the Australian Cancer Research Foundation for a new cancer treatment centre in Brisbane.

The agreement between ACRF and UQDI for the Diamantina Individualised Oncology Care Centre (DIOCC) will mean improved research opportunities and outcomes for cancer patients.

The centre will be based at the Princess Alexandra Hospital and the Translational Research Institute.

Continue reading “Cancer research foundation funds new treatment centre”

Millions in private funding for top cancer research projects in Australia

Five of the best cancer research projects in the world stand to receive millions of dollars in funding,  following the Australian Cancer Research Foundation’s announcement today of its  shortlist for 2013 research grants.

From twelve research proposals, the Australian Cancer Research Foundation (ACRF) has shortlisted five for further assessment as a result of the world-class standard of proposed works, and the significant potential for this research to achieve major breakthroughs in cancer diagnosis, treatment and cure.

Continue reading “Millions in private funding for top cancer research projects in Australia”

Our shortlist of the most innovative cancer research projects in Australia

The ACRF is very excited with the quality of the five shortlisted applications for our grants in 2013. Some of the very best researchers in the world feature in these applications.

These final five applications represent a need for more than $20 million in advanced technologies and facilities. They cover many types of cancer, not just one or two.

Our highly esteemed Medical Research Advisory Committee selected these particular projects for further review on two grounds – the world-class standard of the proposed research, and the potential to achieve major breakthroughs in cancer diagnosis, treatment and cure.

That committee, led by Professor Ian Frazer, will now, through a detailed interview process,  recommend to our Board the best of the best for ACRF funding. The final awardees will be publicly announced on 13 November this year.

Every dollar we receive in donations this year will go to research that has the power to beat cancer. Please peruse the below, to find out where ACRF donations could be making a difference very soon.

Continue reading “Our shortlist of the most innovative cancer research projects in Australia”

Vaccine decreases pre-cancerous symptoms in Aussie women by 93%

Researchers have reported an incredible 93% drop in genital wart diagnoses (symptoms of the human papillomavirus) in young women who have received the HPV, or cervical cancer, vaccine.

The vaccine, co-created by Professor Ian Frazer AC (whose research was supported by an early ACRF seed-funding grant), became available for Australian girls in 2007.

The study, which was conducted by researchers at the University of NSW and the University of Melbourne together with both the Sydney and Melbourne Centres of Sexual Health, looked at the medical data of 85,770 patients during pre-vaccination period (2004-2007) compared to the vaccination period (2007-2011). Continue reading “Vaccine decreases pre-cancerous symptoms in Aussie women by 93%”

ACRF grant rounds open, funding research into all types of cancer

The ACRF is once again inviting world-class research teams and collaborations to apply for between $1.5 and $5 million in ACRF research funding.

Every year we provide major grants to help cutting-edge cancer research institutes develop state-of-the-art facilities, and purchase advanced technologies and equipment that speed up cancer discoveries.

No other private research funding body in Australia provides grants as large as these; and these grants help to fund research in Australia that has the power to make significant breakthroughs in cancer diagnosis and treatment.

Continue reading “ACRF grant rounds open, funding research into all types of cancer”

Up to $10 million in cancer research funding available through the Australian Cancer Research Foundation

The Australian Cancer Research Foundation (ACRF) has begun accepting applications for their 2013 annual Cancer Research Grant Round.

The ACRF provides major grants between $1.5 and $5 million to develop state-of-the-art, collaborative research centres and purchase advanced technologies and equipment. Grants of this magnitude are not available from any other private funding body in Australia.

Continue reading “Up to $10 million in cancer research funding available through the Australian Cancer Research Foundation”

This week: site visits to finalise up to $10 million in cancer research funding!

The ACRF’s scientific advisory committee is on the road this week to assess five world-class cancer research initiatives for potential ACRF funding.

Three of the shortlisted research teams are based in Brisbane, with one in each of Sydney and Melbourne. You can click here to read about each proposed cancer research project.

This week, these research teams will host our scientific experts for site visits and final interviews. These in-depth assessments will ultimately determine the final funding recipients.

The scientific advisory committee is an independent board of 13 esteemed cancer scientists in Australia – it is chaired by Professor Ian Frazer AC, co-creator of the cervical cancer vaccine. The role of the Committee is to identify the most innovative cancer research initiatives in the country and recommend them for ACRF funding. Continue reading “This week: site visits to finalise up to $10 million in cancer research funding!”

Queen’s Birthday Honours List acknowledges four incredible Australians for their services to cancer research

Order of Australia AC Professor Ian Frazer
Professor Ian Frazer. Source: The Australian

 The Australian Cancer Research Foundation would like to congratulate the following four Australians on their appointment to the Order of Australia yesterday via the Queen’s Birthday Honours List. We are so proud and humbled to have the support of these incredible Australians in various aspects of our work:

Professor Ian Frazer, awarded Companion (AC) in the general division: Professor Frazer has been recognised for eminent service to medical research, particularly through leadership roles in the discovery of the human papilloma virus vaccine and its role in preventing cervical cancer. His services to higher education and charitable organisations (Professor Frazer is currently Chairman of the ACRF Medical Research Advisory Committee) have also been acknowledged with this award. Continue reading “Queen’s Birthday Honours List acknowledges four incredible Australians for their services to cancer research”

Professor Frazer seeks vaccine for skin cancer

Professor Ian FrazerChair of the ACRF Medical Research Advisory committee (and co-creator of the cervical cancer vaccine), Professor Ian Frazer is currently working on a world-first strategy to combat skin cancer.

“This group of cancers (skin cancers)…may be started off by a virus infection – which presents a great opportunity, because the idea of vaccinating to prevent a cancer is enormously appealing,” Professor Frazer said.

Professor Frazer believes some virus types, including the wart virus or HPV, are embedded in the layers of the skin, and they pose a skin cancer risk when people with damaged or weak immune systems are overexposed to the sun. Continue reading “Professor Frazer seeks vaccine for skin cancer”

Professor Ian Frazer elected Fellow of The Royal Society

Chairman of the ACRF Medial Research Advisory Committee, Professor Ian Frazer, has been appointed a Fellow of the esteemed Royal Society of London for his ground-breaking research that resulted in a vaccine for cervical cancer.

The 350 year old scientific academy acknowledges some of the most distinguished scientists in the world, with current and previous Fellows including Michael Faraday, Stephen Hawking and Isaac Newton.

“Election to The Royal Society is a great and unexpected honor, providing an opportunity to interact with the world’s leading scientists,” Professor Frazer said. Continue reading “Professor Ian Frazer elected Fellow of The Royal Society”

PM's science award to Professor Ian Frazer

Professor Ian Frazer, co-creator of the cervical cancer vaccine, has won the 2008 Prime Minister¹s Prize for Science. Professor Frazer, recently appointed as the next Chairman of the Australian Cancer Research Foundation’s Medical Research Advisory Committee (MRAC) is a Director of the Diamantina Institute for Cancer, Immunology and Metabolic Medicine at the Unviersity of Queensland.

Professor Frazer was presented with his prize by Prime Minister, Kevin Rudd, at a special ceremony in the Great Hall, Parliament House Canberra.

The Prime Minister’s Prize for Science is the nation’s pre-eminent award for excellence in science and acknowledges the contributions of Australian scientists to economic and social wellbeing in Australia and the world. Awarded for an outstanding specific achievement in any area of science advancing human welfare or benefiting society, it can encompass the physical, chemical, biological and technological sciences, mathematics and/or engineering.

Continue reading “PM's science award to Professor Ian Frazer”

Congratulations Professor Frazer

A member of this Foundation’s Medical Research Advisory Committee, Professor Ian Frazer has been awarded the prestigious Florey Medal for Medical Research honouring his work in discovering the HPV vaccine to eradicate cervical cancer.

The prestigious Florey award is named in honour of Australia’s first Nobel Laureate in Medicine, Howard Florey, who invented penicillin.

Professor Frazer, last year’s Australian of the Year, said he was honoured to receive the award on behalf of the team of people involved in developing human papillomavirus (HPV) cervical cancer vaccines, especially his UQ colleague, the late Dr Jian Zhou.

His discovery, a result of 20 years of research, has the potential to eradicate a cancer that annually kills close to 300,000 women worldwide.

Continue reading “Congratulations Professor Frazer”

Professor Ian Frazer appointed to MRAC

2006 Australian of the Year Professor Ian Frazer has been appointed to the ACRF’s Medical Research Advisory Committee (MRAC).

Frazer joins eight other highly established national scientists on the Committee, who are collectively charged with considering the Foundation’s research applications

Professor Ian Frazer, the founder and leader of the University of Queensland’s Centre for Immunology and Cancer Research, has proven the link between cervical cancers and the papilloma virus.

After almost 20 years of research, he has developed a vaccine with the potential to eradicate cervical cancer within a decade. The vaccine has been proven to prevent infection and reduces pap smear abnormalities by 90%. The preventive vaccine will revolutionise women’s health in Australia and across the globe.

Professor Frazer was helped in his quest to develop the vaccine by a $1million ACRF grant to the Centre for Immunology and Cancer Research in 1999.

Procedures of the MRAC include assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed candidates. Membership of the Committee is authorised by the Department of Health. Each member is appointed on a three yearly basis, after which they may either stand down or seek re-election.

Ian Frazer Vaccine

Last year, Professor Ian Frazer (Australian of The Year) and his team were able to create a vaccine that prevents cervical cancer by up to an astonishing 70% . With a little more help, who knows what we can achieve this year.

There’s never been a better time to donate.

Contact us on 1300 884 988 or make a secure online donation now.

ACRF research funds critical to keeping international edge: Frazer

The AProfessor Ian FrazerCRF extends its congratulations to Professor Ian FrazerAustralian of the Year 2006.

Professor Frazer, from Brisbane, was given the award for his outstanding medical research. The founder and leader of the University of Queensland’s Centre for Immunology and Cancer Research, Professor Frazer has proven the link between cervical cancers and the papilloma virus.

After almost 20 years of research, he has developed a vaccine with the potential to eradicate cervical cancer within a decade.

The vaccine is in the final stages of world-wide trials. It has been proven to prevent infection and reduces pap smear abnormalities by 90%. Expected to be on the market by the end of 2006, his preventive vaccine will revolutionise women’s health in Australia and across the globe. Currently, the disease affects 500,000 women each year.

Professor Frazer, guest speaker at the ACRF Chairman’s Dinner, was helped in his quest to develop the vaccine by a $1million ACRF grant to the Centre for Immunology and Cancer Research in 1999.

Continue reading “ACRF research funds critical to keeping international edge: Frazer”